Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. et al
Case Number:
3:16-cv-00443
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Faegre Drinker
- Holland & Knight
- Irell & Manella
- King & Spalding
- Milbank LLP
- Morrison Foerster
- Orrick Herrington
- Patterson Belknap
- Shook Hardy
- White & Case
Companies
- AIDS Healthcare Foundation
- Akros Pharma Inc.
- Bristol-Myers Squibb Co.
- Fraternal Order of Police
- Gilead Sciences Inc.
- Japan Tobacco
- Johnson & Johnson
Sectors & Industries:
-
July 12, 2016
Gilead AIDS Drug Antitrust Case To Get Appeal
The AIDS Healthcare Foundation will appeal a California federal judge's decision last week that dismissed the group's antitrust and patent invalidation claims against Gilead Sciences Inc. over HIV treatments, the foundation said on Monday.
-
July 06, 2016
Gilead Beats Antitrust Suit Over HIV Drug Patents
AIDS Healthcare Foundation Inc. can't invalidate five patents for HIV treatments or support antitrust claims against Gilead Sciences Inc., a California federal judge said Wednesday as he dismissed the case in its entirety.
-
May 13, 2016
AIDS Group Agrees To Drop 2 Cos. From Drug Antitrust Row
AIDS Healthcare Foundation Inc. has agreed to dismiss two companies from its lawsuit alleging the entities violated federal antitrust law by joining efforts by Gilead Sciences Inc. to block affordable access to lifesaving HIV treatments and monopolize the market based on invalid patents.
-
March 23, 2016
Gilead Says Patent, Antitrust Claims Over HIV Drug Fail
Gilead Sciences has asked a California federal judge to dismiss a patent and antitrust lawsuit over its new HIV treatment Genvoya, saying the AIDS Healthcare Foundation failed to identify any harm to competition or a real and immediate patent dispute.
-
January 26, 2016
Gilead Hit With Suit In HIV Drug Patent Manipulation Row
AIDS Healthcare Foundation Inc. on Tuesday filed a California federal suit seeking to invalidate patents for Gilead Sciences Inc.'s HIV/AIDS prevention drug Genvoya and also accused the company of blocking affordable access to lifesaving HIV treatments by monopolizing the market.